Market Research Logo

Aplastic Anemia - Pipeline Review, H2 2018

Aplastic Anemia - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia - Pipeline Review, H2 2018, provides an overview of the Aplastic Anemia (Hem


Introduction
Global Markets Direct Report Coverage
Aplastic Anemia - Overview
Aplastic Anemia - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Aplastic Anemia - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Aplastic Anemia - Companies Involved in Therapeutics Development
Acceleron Pharma Inc
Amgen Inc
BioLineRx Ltd
Cell Source Inc
Cellenkos Inc
F. Hoffmann-La Roche Ltd
Gamida Cell Ltd
Jiangsu Hengrui Medicine Co Ltd
Regen BioPharma Inc
Aplastic Anemia - Drug Profiles
Anemir - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BL-8040 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cell Therapy for Aplastic Anemia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cellular Immunotherapy for Aplastic Anemia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cellular Immunotherapy for Hematological Disorders - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CK-0801 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CordIn - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EXG-34217 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy to Activate Telomerase for Aplastic Anemia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HemaXellerate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Hetrombopag Olamine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
romiplostim - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
sotatercept - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Aplastic Anemia - Dormant Projects
Aplastic Anemia - Discontinued Products
Aplastic Anemia - Product Development Milestones
Featured News & Press Releases
Jul 31, 2018: Kyowa Hakko Kirin submits application for additional indication for Romiplostim (Recombinant) for aplastic anemia in Japan
Oct 24, 2016: Pan Am Cancer Treatment Center Provides Final HemaXellerate Clinical Data to Regen BioPharma, for treatment of Bone Marrow Suppression Study
Sep 22, 2016: Regen BioPharma Responds to FDA Comments on Its Application for Orphan Drug Designation on its Aplastic Anemia Therapy
May 11, 2016: Regen BioPharma Discusses Recent Developments in Aplastic Anemia Therapy and Future Potential Expansion of HemaXellerate
May 03, 2016: Regen BioPharma Receives Preliminary Clinical Data from Pan Am Cancer Center Regarding Their HemaXellerate Study in Cancer Patients
Jan 26, 2016: Regen BioPharma Submits Application to FDA for Orphan Drug Designation for its HemaXellerate Product
Dec 15, 2015: Regen BioPharma Receives FDA Clearance to Initiate Clinical Trial of HemaXellerate
Nov 23, 2015: BioLineRx Announces Initiation of Phase 1/2 Trial for Novel Treatment in Two Bone Marrow Failure Conditions
Nov 17, 2015: Regen BioPharma Submits Response to FDA Questions on HemaXellerate Investigational New Drug Application
Sep 25, 2015: Regen BioPharma Announces Positive Results from GLP Safety Study for HemaXellerate
Sep 10, 2015: BioLineRx Announces Regulatory Submission for Phase 2 Trial of BL-8040 as Novel Treatment for Hypoplastic Myelodysplastic Syndrome and Aplastic Anemia
Jul 21, 2015: Regen BioPharma Successfully Completes in Life Portion of Experiments Requested by FDA for HemaXellerate Pre-Clinical Study
Jul 09, 2015: Regen BioPharma Reports Successful Dosing of HemaXellerate in FDA-Requested GLP Animal Study
May 05, 2015: Regen BioPharma presents HemaXellerate at the 13th International Symposium on Myelodysplastic Syndromes Held April 29 to May 2, 2015 in Washington, DC
Apr 22, 2015: Regen BioPharma Engages Charles River Laboratories to Initiate FDA-Requested Study to Support Initiation of HemaXellerate Clinical Trial
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Aplastic Anemia, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Aplastic Anemia - Pipeline by Acceleron Pharma Inc, H2 2018
Aplastic Anemia - Pipeline by Amgen Inc, H2 2018
Aplastic Anemia - Pipeline by BioLineRx Ltd, H2 2018
Aplastic Anemia - Pipeline by Cell Source Inc, H2 2018
Aplastic Anemia - Pipeline by Cellenkos Inc, H2 2018
Aplastic Anemia - Pipeline by F. Hoffmann-La Roche Ltd, H2 2018
Aplastic Anemia - Pipeline by Gamida Cell Ltd, H2 2018
Aplastic Anemia - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2 2018
Aplastic Anemia - Pipeline by Regen BioPharma Inc, H2 2018
Aplastic Anemia - Dormant Projects, H2 2018
Aplastic Anemia - Discontinued Products, H2 2018
List of Figures
Number of Products under Development for Aplastic Anemia, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products by Targets, H2 2018
Number of Products by Stage and Targets, H2 2018
Number of Products by Mechanism of Actions, H2 2018
Number of Products by Stage and Mechanism of Actions, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report